Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 140 articles: HTML format

Single Articles

April 2024
1. MATHUR M, Barratt J, Suzuki Y
   Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Reply.
   N Engl J Med. 2024;390:1245-1246.
   PubMed    
   
   
   
2. BELMONT HM
   Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
   N Engl J Med. 2024;390:1245.
   PubMed    
   
   
   
3. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
   Prevention of Cardiovascular Disease in Type 1 Diabetes.
   N Engl J Med. 2024;390:1207-1217.
   PubMed    
   
   
   March 2024
4. NETEA MG, van de Veerdonk FL
   Anti-Interleukin-23 Autoantibodies and Severe Infections.
   N Engl J Med. 2024;390:1143-1146.
   PubMed    
   
   
   
5. CHENG A, Kashyap A, Salvator H, Rosen LB, et al
   Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
   N Engl J Med. 2024;390:1105-1117.
   PubMed     Abstract available
   
   
   
6. DRIVENES JL, Bygum A
   Spontaneous Oral Purpura in Immune Thrombocytopenia.
   N Engl J Med. 2024;390:1029.
   PubMed    
   
   
   
7. WECHSLER ME, Nair P, Terrier B, Walz B, et al
   Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
   N Engl J Med. 2024;390:911-921.
   PubMed     Abstract available
   
   
   February 2024
8. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
   CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
   N Engl J Med. 2024;390:687-700.
   PubMed     Abstract available
   
   
   
9. ISAACS JD
   CAR T Cells - A New Horizon for Autoimmunity?
   N Engl J Med. 2024;390:758-759.
   PubMed    
   
   
   
10. HAUSER SL
    Silencing Immune Dialogue in Multiple Sclerosis.
    N Engl J Med. 2024;390:662-663.
    PubMed    
    
    
    
11. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med. 2024;390:589-600.
    PubMed     Abstract available
    
    
    January 2024
12. DANDONA P, Chaudhuri A, Ghanim H
    More on Semaglutide in Early Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:292.
    PubMed    
    
    
    
13. GAGLIA JL, Laffel LM, Patti ME
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    PubMed    
    
    
    
14. WEINRAUCH LA, D'Elia JA
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    PubMed    
    
    
    
15. DEVRIES JH
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:290.
    PubMed    
    
    
    
16. HADZIC N, Deheragoda M, Worth A, Bansal S, et al
    JAK Inhibition in STAT1 Gain-of-Function-Mediated Treatment-Resistant Autoimmune Hepatitis.
    N Engl J Med. 2024;390:284-286.
    PubMed    
    
    
    
17. LEE TTM, Bergford S, Murphy HR
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:184.
    PubMed    
    
    
    
18. GRZYCH G, Kim I
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183-184.
    PubMed    
    
    
    
19. VIVANTI AJ, Benachi A, Voican A
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183.
    PubMed    
    
    
    
20. LEMLEY KV, Glassock RJ
    APRIL - Springtime for New IgA Nephropathy Therapy?
    N Engl J Med. 2024;390:80-81.
    PubMed    
    
    
    
21. LIU MJ, Li J
    Necrobiosis Lipoidica.
    N Engl J Med. 2024;390:70.
    PubMed    
    
    
    December 2023
22. ARJUNAN D, Bhadada SK
    Thyroid Dermopathy in Graves' Disease.
    N Engl J Med. 2023;389:2376.
    PubMed    
    
    
    
23. LUDVIGSSON J
    Immune Interventions at Onset of Type 1 Diabetes - Finally, a Bit of Hope.
    N Engl J Med. 2023;389:2199-2201.
    PubMed    
    
    
    
24. WAIBEL M, Wentworth JM, So M, Couper JJ, et al
    Baricitinib and beta-Cell Function in Patients with New-Onset Type 1 Diabetes.
    N Engl J Med. 2023;389:2140-2150.
    PubMed     Abstract available
    
    
    November 2023
25. EL-ZAATARI ZM
    Anti-Glomerular Basement Membrane Glomerulonephritis.
    N Engl J Med. 2023;389:1901.
    PubMed    
    
    
    
26. BUSSEL JB, Hou M, Cines DB
    Primary Immune Thrombocytopenia in Pregnancy. Reply.
    N Engl J Med. 2023;389:1728.
    PubMed    
    
    
    
27. TRAN BW, May KA, Pal N
    Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:1728.
    PubMed    
    
    
    
28. MATHUR M, Barratt J, Chacko B, Chan TM, et al
    A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
    N Engl J Med. 2023 Nov 2. doi: 10.1056/NEJMoa2305635.
    PubMed     Abstract available
    
    
    October 2023
29. RAMOS EL, Dayan CM, Chatenoud L, Sumnik Z, et al
    Teplizumab and beta-Cell Function in Newly Diagnosed Type 1 Diabetes.
    N Engl J Med. 2023 Oct 18. doi: 10.1056/NEJMoa2308743.
    PubMed     Abstract available
    
    
    
30. LINDHOFF-LAST E, Schonborn L, Zaninetti C, Warkentin TE, et al
    Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 Disorder.
    N Engl J Med. 2023;389:1339-1341.
    PubMed    
    
    
    
31. SPIERA RF, Unizony S, Warrington KJ, Sloane J, et al
    Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
    N Engl J Med. 2023;389:1263-1272.
    PubMed     Abstract available
    
    
    
32. LEE TTM, Collett C, Bergford S, Hartnell S, et al
    Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMoa2303911.
    PubMed     Abstract available
    
    
    
33. GARG SK, Polsky S
    Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMe2310798.
    PubMed    
    
    
    
34. ALETAHA D
    Polymyalgia Rheumatica - from Search for Efficacy to Choice of Strategy.
    N Engl J Med. 2023;389:1328-1329.
    PubMed    
    
    
    September 2023
35. BRODERICK L, Kastner DL
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome. Reply.
    N Engl J Med. 2023;389:1151-1152.
    PubMed    
    
    
    
36. PASTORE S, De Martino E, Taddio A
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome.
    N Engl J Med. 2023;389:1151.
    PubMed    
    
    
    
37. WANG WY, Cheng ST
    Sleeve Sign and Inverse Gottron's Papules in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2023;389:1032.
    PubMed    
    
    
    
38. DANDONA P, Chaudhuri A, Ghanim H
    Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2023;389:958-959.
    PubMed    
    
    
    August 2023
39. FUKUSHIMA H, Matsumoto M
    Cold Agglutinin Syndrome.
    N Engl J Med. 2023;389:642.
    PubMed    
    
    
    
40. BUSSEL JB, Hou M, Cines DB
    Management of Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:540-548.
    PubMed    
    
    
    
41. WARKENTIN TE, Baskin-Miller J, Raybould AL, Sheppard JI, et al
    Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies.
    N Engl J Med. 2023;389:574-577.
    PubMed    
    
    
    
42. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    PubMed    
    
    
    
43. KOOSHESH KA, Foy BH, Sykes DB, Gustafsson K, et al
    Health Consequences of Thymus Removal in Adults.
    N Engl J Med. 2023;389:406-417.
    PubMed     Abstract available
    
    
    June 2023
44. WADWA RP, Beck RW, Breton MD
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:2206-2207.
    PubMed    
    
    
    
45. SHIBUE K
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2206.
    PubMed    
    
    
    
46. HSU NC, Hsu CH
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2205-2206.
    PubMed    
    
    
    
47. LEE CD, Galetta SL, Dobson R
    Management of Possible Multiple Sclerosis.
    N Engl J Med. 2023;388:2195-2198.
    PubMed    
    
    
    May 2023
48. BAGHDASSARIAN H, Blackstone SA, Clay OS, Philips R, et al
    Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
    N Engl J Med. 2023 May 31. doi: 10.1056/NEJMoa2202318.
    PubMed     Abstract available
    
    
    April 2023
49. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    PubMed    
    
    
    March 2023
50. BRUTTOMESSO D
    Technology in the Changing Management of Diabetes in Children.
    N Engl J Med. 2023;388:1052-1054.
    PubMed    
    
    
    
51. LEE AI, Heidari P, Fenves AZ, Bardia A, et al
    Case 8-2023: A 71-Year-Old Woman with Refractory Hemolytic Anemia.
    N Engl J Med. 2023;388:1032-1041.
    PubMed    
    
    
    
52. WADWA RP, Reed ZW, Buckingham BA, DeBoer MD, et al
    Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:991-1001.
    PubMed     Abstract available
    
    
    January 2023
53. RUSSELL SJ, Damiano ER, Calhoun P
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:380-382.
    PubMed    
    
    
    
54. KHOO TK
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    PubMed    
    
    
    
55. MURATA Y, Takita M, Kami M
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    PubMed    
    
    
    
56. AGGARWAL R, Charles-Schoeman C, Schessl J
    Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
    N Engl J Med. 2023;388:94-95.
    PubMed    
    
    
    
57. WERTH VP, Fiorentino DF, Vleugels RA
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2023;388:94.
    PubMed    
    
    
    November 2022
58. BURNSIDE MJ, Williman JA, de Bock MI
    Open-Source Automated Insulin Delivery in Type 1 Diabetes. Reply.
    N Engl J Med. 2022;387:2007-2008.
    PubMed    
    
    
    
59. SCARAMUZZA AE, Cherubini V, Rabbone I
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006-2007.
    PubMed    
    
    
    
60. MURATA Y, Takita M, Kami M
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006.
    PubMed    
    
    
    
61. BRENNAN T
    Pharmaceutical Marketing Revisited - United States v. Biogen Idec.
    N Engl J Med. 2022;387:1631-1633.
    PubMed    
    
    
    October 2022
62. WERTH VP, Barbey C, Franchimont N
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus. Reply.
    N Engl J Med. 2022;387:1529.
    PubMed    
    
    
    
63. PSARRAS A, Vital EM
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:1528-1529.
    PubMed    
    
    
    
64. REBELLO A, Joshi P
    Giant-Cell Arteritis.
    N Engl J Med. 2022;387:e36.
    PubMed    
    
    
    
65. AMATO AA
    Intravenous Immune Globulin Therapy in Dermatomyositis.
    N Engl J Med. 2022;387:1320-1321.
    PubMed    
    
    
    
66. AGGARWAL R, Charles-Schoeman C, Schessl J, Bata-Csorgo Z, et al
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2022;387:1264-1278.
    PubMed     Abstract available
    
    
    
67. LEELARATHNA L, Evans ML, Neupane S, Rayman G, et al
    Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.
    N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMoa2205650.
    PubMed     Abstract available
    
    
    September 2022
68. RUSSELL SJ, Beck RW, Damiano ER, El-Khatib FH, et al
    Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2022;387:1161-1172.
    PubMed     Abstract available
    
    
    
69. COLIZZO FP, Shroff SG, High FA, Chen YB, et al
    Case 29-2022: A 33-Year-Old Man with Chronic Diarrhea and Autoimmune Enteropathy.
    N Engl J Med. 2022;387:1124-1134.
    PubMed    
    
    
    
70. HERRERA-COMOGLIO R, Lane S
    Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210813.
    PubMed    
    
    
    
71. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    PubMed     Abstract available
    
    
    
72. BOLINDER J
    CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion.
    N Engl J Med. 2022;387:937-938.
    PubMed    
    
    
    
73. BOUGHTON CK, Allen JM, Ware J, Wilinska ME, et al
    Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
    N Engl J Med. 2022;387:882-893.
    PubMed     Abstract available
    
    
    
74. BURNSIDE MJ, Lewis DM, Crocket HR, Meier RA, et al
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:869-881.
    PubMed     Abstract available
    
    
    August 2022
75. STEINMAN L, Fox E, Hartung HP, Alvarez E, et al
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med. 2022;387:704-714.
    PubMed     Abstract available
    
    
    
76. WINGERCHUK DM, Lucchinetti CF
    Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2022;387:631-639.
    PubMed    
    
    
    July 2022
77. WERTH VP, Furie RA, Romero-Diaz J, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:321-331.
    PubMed     Abstract available
    
    
    June 2022
78. KUTER DJ
    Rilzabrutinib in Immune Thrombocytopenia. Reply.
    N Engl J Med. 2022;386:2538.
    PubMed    
    
    
    
79. MURAKAMI J, Senoo Y, Tanimoto T
    Rilzabrutinib in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:2537-2538.
    PubMed    
    
    
    
80. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    PubMed    
    
    
    
81. HUANG YM, Lin PH
    IgG4-Related Ophthalmic Disease.
    N Engl J Med. 2022;386:2315.
    PubMed    
    
    
    
82. JEBARAJ A, Lin A
    Sclerokeratitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:2221.
    PubMed    
    
    
    April 2022
83. WARE J, Hovorka R
    Closed-Loop Control in Very Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2022;386:1482-1483.
    PubMed    
    
    
    
84. RING BL
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    PubMed    
    
    
    
85. MURATA Y, Takita M, Kami M
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    PubMed    
    
    
    
86. KUTER DJ, Efraim M, Mayer J, Trneny M, et al
    Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:1421-1431.
    PubMed     Abstract available
    
    
    March 2022
87. SPERLING MA, Laffel LM
    Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
    N Engl J Med. 2022;386:1155-1164.
    PubMed    
    
    
    
88. COSTENBADER KH
    A New IMiD for Systemic Lupus Erythematosus - Tempering Our Excitement.
    N Engl J Med. 2022;386:1085-1086.
    PubMed    
    
    
    
89. MERRILL JT, Werth VP, Furie R, van Vollenhoven R, et al
    Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
    N Engl J Med. 2022;386:1034-1045.
    PubMed     Abstract available
    
    
    January 2022
90. YONG GY, Lim AL
    Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:374.
    PubMed    
    
    
    
91. WARE J, Allen JM, Boughton CK, Wilinska ME, et al
    Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:209-219.
    PubMed     Abstract available
    
    
    
92. VIDENOVIC A, Babu S, Zhao B, Reda HM, et al
    Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep.
    N Engl J Med. 2022;386:173-180.
    PubMed    
    
    
    
93. PAVORD S, Lester W, Hunt BJ
    Clinical Features of VITT. Reply.
    N Engl J Med. 2022;386.
    PubMed    
    
    
    
94. CHITI A
    Clinical Features of VITT.
    N Engl J Med. 2022;386.
    PubMed    
    
    
    December 2021
95. LACY J, Pavord S, Brown KE
    VITT and Second Doses of Covid-19 Vaccine.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2118507.
    PubMed    
    
    
    
96. DILLY B, Bomahou C
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2021;385:2377.
    PubMed    
    
    
    
97. BRADBURY CA, Hill Q, Greenwood R
    Mycophenolate Mofetil for Immune Thrombocytopenia. Reply.
    N Engl J Med. 2021;385:2201-2202.
    PubMed    
    
    
    
98. VAN DIJK WEM, Schutgens REG
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2201.
    PubMed    
    
    
    
99. GHANIMA W, Zaja F, Michel M
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2200-2201.
    PubMed    
    
    
    
100. CHEN S, Dong C, Wei JC
     Mycophenolate Mofetil for Immune Thrombocytopenia.
     N Engl J Med. 2021;385:2200.
     PubMed    
     
     
     November 2021
101. O'CONNELL J, Nathan DM, O'Brien T, O'Keeffe DT, et al
     Treatment of Diabetes - To Pump or Not to Pump.
     N Engl J Med. 2021;385:2092-2095.
     PubMed    
     
     
     
102. MANDL A, Burbelo PD, Di Pasquale G, Tay YS, et al
     Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.
     N Engl J Med. 2021;385:1974-1980.
     PubMed     Abstract available
     
     
     
103. BJORNSTAD P, Drews K, Zeitler PS
     Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply.
     N Engl J Med. 2021;385:2016.
     PubMed    
     
     
     
104. NELSON RG, Hanson RL, Knowler WC
     Long-Term Complications in Youth-Onset Type 2 Diabetes.
     N Engl J Med. 2021;385:2015.
     PubMed    
     
     
     
105. YANG W, Wang C
     Long-Term Complications in Youth-Onset Type 2 Diabetes.
     N Engl J Med. 2021;385:2014-2015.
     PubMed    
     
     
     
106. MOUGIAKAKOS D, Kronke G, Schett G
     More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
     N Engl J Med. 2021;385:e67.
     PubMed    
     
     
     
107. KONIG MF, Paul S
     More on CD19-CAR T Cells in Systemic Lupus Erythematosus.
     N Engl J Med. 2021;385:e67.
     PubMed    
     
     
     
108. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
     Decline in Pathogenic Antibodies over Time in VITT.
     N Engl J Med. 2021;385:1815-1816.
     PubMed    
     
     
     October 2021
109. BERENTSEN S, Barcellini W
     Autoimmune Hemolytic Anemias.
     N Engl J Med. 2021;385:1407-1419.
     PubMed    
     
     
     September 2021
110. MATTHIESEN MI, Shailam R, Rothermel H
     Case 29-2021: A 12-Month-Old Boy with Fever and Developmental Regression.
     N Engl J Med. 2021;385:1220-1229.
     PubMed    
     
     
     
111. TSUI JC, Onishi S
     Symblepharon in Linear IgA Bullous Dermatosis.
     N Engl J Med. 2021;385:1219.
     PubMed    
     
     
     
112. WERTH VP, Joly P, Chen DM
     Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
     N Engl J Med. 2021;385:1056.
     PubMed    
     
     
     
113. HOPKINS ZH, Wu BC, Nousari CH
     Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
     N Engl J Med. 2021;385:1055-1056.
     PubMed    
     
     
     
114. BOLTON-MAGGS PHB, George JN
     Immune Thrombocytopenia Treatment.
     N Engl J Med. 2021;385:948-950.
     PubMed    
     
     
     
115. BRADBURY CA, Pell J, Hill Q, Bagot C, et al
     Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
     N Engl J Med. 2021;385:885-895.
     PubMed     Abstract available
     
     
     August 2021
116. PAVORD S, Scully M, Hunt BJ, Lester W, et al
     Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
     N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
     PubMed     Abstract available
     
     
     
117. GOYAL RK
     Gastric Emptying Abnormalities in Diabetes Mellitus. Reply.
     N Engl J Med. 2021;385:576.
     PubMed    
     
     
     
118. AKTURK HK, Shah VN
     Gastric Emptying Abnormalities in Diabetes Mellitus.
     N Engl J Med. 2021;385:575-576.
     PubMed    
     
     
     
119. MOUGIAKAKOS D, Kronke G, Volkl S, Kretschmann S, et al
     CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
     N Engl J Med. 2021;385:567-569.
     PubMed    
     
     
     July 2021
120. SMIBERT OC, Catalano OA, Goodarzi K, Roberts MB, et al
     Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia.
     N Engl J Med. 2021;385:451-460.
     PubMed    
     
     
     
121. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
     A Periodic Problem.
     N Engl J Med. 2021;385:e17.
     PubMed    
     
     
     
122. AVELAR RODRIGUEZ D, Orkin J
     An Icteric Tongue.
     N Engl J Med. 2021;385:e16.
     PubMed    
     
     
     
123. MORAN-THOMAS A
     One Hundred Years of Insulin for Some.
     N Engl J Med. 2021;385:293-295.
     PubMed    
     
     
     
124. GOGLIN SE, Margaretten ME
     Malar Rash.
     N Engl J Med. 2021;385:164.
     PubMed    
     
     
     
125. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
     Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
     N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
     PubMed    
     
     
     June 2021
126. O'CONNELL KA, LaChance AH
     Dermatomyositis.
     N Engl J Med. 2021;384:2437.
     PubMed    
     
     
     
127. SEEKER P, Osswald S
     Tongue Discoloration.
     N Engl J Med. 2021;384:e102.
     PubMed    
     
     
     
128. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
     Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
     N Engl J Med. 2021;384:2295-2305.
     PubMed     Abstract available
     
     
     May 2021
129. JAYNE DRW, Merkel PA, Bekker P
     Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
130. MATSUO Y, Miyabe Y
     Avacopan for the Treatment of ANCA-Associated Vasculitis.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
131. CHANDWAR K
     Avacopan for the Treatment of ANCA-Associated Vasculitis.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
132. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
     A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
     N Engl J Med. 2021;384:2014-2027.
     PubMed     Abstract available
     
     
     
133. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
     Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
     N Engl J Med. 2021;384:1849-1857.
     PubMed    
     
     
     
134. FRALICK M, Sarma S
     Thyrotoxic Periodic Paralysis.
     N Engl J Med. 2021;384:e71.
     PubMed    
     
     
     
135. MOHAMED F, Raal FJ
     Hyperpigmentation from Addison's Disease.
     N Engl J Med. 2021;384:1752.
     PubMed    
     
     
     April 2021
136. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
     Case 13-2021: A Newborn Girl with a Neck Mass.
     N Engl J Med. 2021;384:1647-1655.
     PubMed    
     
     
     
137. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
     Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
     N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
     PubMed     Abstract available
     
     
     
138. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
     Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
     N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
     PubMed     Abstract available
     
     
     
139. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
     Sutimlimab in Cold Agglutinin Disease.
     N Engl J Med. 2021;384:1323-1334.
     PubMed     Abstract available
     
     
     
140. ZONOZI R, Niles JL
     Sunken Nose.
     N Engl J Med. 2021;384:e52.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.